In a large cohort of postmenopausal women, calcium and vitamin D (CaD) supplementation had no effect on incidence of atrial fibrillation (AF), a recent study found. Researchers performed a secondary analysis of the Women’s Health Initiative (WHI) trial on CaD supplementation vs placebo to determine its efficacy for AF prevention. They found:
- Among 16,801 WHI participants, there were 1,453 (8.6%) cases of incident AF over an average of 4.5 years, at an average rate of 19.9 events per 1,000 person-years.
- There was no significant difference in incident AF rates between the CaD and placebo arms.
- After multivariate adjustment, there was no significant association between baseline 25-hydroxyvitamin D serum levels and incident AF.
Boursiquot BC, Larson JC, Shalash OA, et al. Vitamin D with calcium supplementation and risk of atrial fibrillation in postmenopausal women. [Published online ahead of print December 13, 2018]. Am Heart J. doi:10.1016/j.ahj.2018.12.006.
This Week's Must Reads
Must Reads in Arrhythmias & EP
Impact of HF Type on Bleeding Risk in Patients with AF, Am J Cardiol; ePub 2019 Feb 28; Mentias, et al